Ifp Advisors, Inc Novo Cure LTD Transaction History

Ifp Advisors, Inc

$3.07 Billion
Q1 2025

A detailed history of Ifp Advisors, Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Ifp Advisors, Inc holds 461 shares of NVCR stock, worth $7,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares

461

Previous 476 3.15%

Holding current value

$7,583

Previous $14,000 42.86%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$17.82 - $30.19 $267 - $452	-15 Reduced 3.15%	461 $8,000
Q4 2024 Feb 04, 2025	BUY	$14.54 - $33.41 $247 - $567	17 Added 3.7%	476 $14,000
Q3 2024 Feb 04, 2025	SELL	$15.61 - $23.34 $655 - $980	-42 Reduced 8.38%	459 $7,000
Q1 2024 Jul 30, 2024	SELL	$12.42 - $17.29 $1,105 - $1,538	-89 Reduced 15.08%	501 $7,000
Q4 2023 Jan 09, 2024	BUY	$11.13 - $15.78 $5,119 - $7,258	460 Added 353.85%	590 $8,000
Q3 2023 Oct 12, 2023	BUY	$16.15 - $42.35 $791 - $2,075	49 Added 60.49%	130 $2,000
Q2 2023 Aug 04, 2023	SELL	$40.29 - $82.51 $52,578 - $107,675	-1,305 Reduced 94.16%	81 $3,000
Q1 2023 Apr 18, 2023	SELL	$56.44 - $118.81 $122,757 - $258,411	-2,175 Reduced 61.08%	1,386 $83,000
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $1,151 - $1,536	18 Added 0.51%	3,561 $123,000
Q3 2022 Nov 08, 2022	BUY	$67.99 - $89.57 $815 - $1,074	12 Added 0.34%	3,543 $121,000
Q2 2022 Sep 06, 2022	BUY	$56.6 - $89.9 $199,854 - $317,436	3,531 New	3,531 $120,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $199,854 - $317,436	-3,531 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$60.15 - $84.52 $72,480 - $101,846	1,205 Added 51.81%	3,531 $292,000
Q1 2022 Aug 08, 2022	BUY	$60.15 - $84.52 $7,578 - $10,649	126 Added 5.73%	2,326 $192,000
Q4 2021 Jan 12, 2022	BUY	$75.08 - $121.99 $13,589 - $22,080	181 Added 8.96%	2,200 $169,000
Q3 2021 Oct 06, 2021	SELL	$116.17 - $194.55 $348 - $583	-3 Reduced 0.15%	2,019 $236,000
Q2 2021 Jul 13, 2021	SELL	$130.4 - $225.58 $5,216 - $9,023	-40 Reduced 1.94%	2,022 $449,000
Q1 2021 Apr 30, 2021	SELL	$124.11 - $190.17 $46,913 - $71,884	-378 Reduced 15.49%	2,062 $273,000
Q4 2020 Jan 25, 2021	BUY	$112.16 - $174.14 $64,940 - $100,827	579 Added 31.11%	2,440 $421,000
Q3 2020 Oct 29, 2020	SELL	$58.05 - $111.31 $6,385 - $12,244	-110 Reduced 5.58%	1,861 $204,000
Q2 2020 Aug 05, 2020	BUY	$57.2 - $74.41 $8,522 - $11,087	149 Added 8.18%	1,971 $116,000
Q1 2020 May 12, 2020	BUY	$57.05 - $95.75 $36,397 - $61,088	638 Added 53.89%	1,822 $125,000
Q4 2019 Jan 17, 2020	BUY	$68.3 - $93.8 $26,568 - $36,488	389 Added 48.93%	1,184 $103,000
Q3 2019 Nov 07, 2019	BUY	$61.86 - $97.8 $47,013 - $74,328	760 Added 2171.43%	795 $59,000
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $55,162 - $96,863	-1,726 Reduced 98.01%	35 $2,000
Q4 2018 Jan 23, 2019	BUY	$28.72 - $52.63 $2,757 - $5,052	96 Added 5.77%	1,761 $58,000
Q3 2018 Oct 25, 2018	BUY	$32.0 - $52.4 $35,200 - $57,640	1,100 Added 194.69%	1,665 $0
Q2 2018 Aug 07, 2018	BUY	$19.85 - $32.0 $6,252 - $10,080	315 Added 126.0%	565 $0
Q1 2018 May 09, 2018	BUY	$19.3 - $23.65 $4,149 - $5,084	215 Added 614.29%	250 $0
Q1 2016 Jun 03, 2019	BUY	N/A	35	35 $2,000

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.73B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account